CoreFirst Bank & Trust’s MiMedx Group MDXG Stock Holding History

CoreFirst Bank & Trust’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,300	Closed	-$49K	–	420
2022 Q1	$49K	Hold	10,300	–	–	0.03%	246
2021 Q4	$62K	Hold	10,300	–	–	0.04%	232
2021 Q3	$62K	Hold	10,300	–	–	0.04%	228
2021 Q2	$129K	Hold	10,300	–	–	0.09%	168
2021 Q1	$106K	Hold	10,300	–	–	0.07%	179
2020 Q4	$94K	Buy	+10,300	New	+$74.1K	0.07%	176

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BMO

Beck Mack & Oliver New York $4.85B AUM 9.66% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

CoreFirst Bank & Trust's MDXG Position: Q2 2022 in Review

CoreFirst Bank & Trust sold out of MiMedx Group (MDXG) in Q2 2022, closing a stake of 10,300 shares — an estimated $49K sold.

CoreFirst Bank & Trust first reported a position in MDXG in Q4 2020 and held it in 6 quarters. The position peaked at $129K in Q2 2021. 153 funds tracked by Wall St. Rank hold MDXG as of Q2 2022.

CoreFirst Bank & Trust reported no remaining MiMedx Group position as of Q2 2022 after selling out during the quarter.
CoreFirst Bank & Trust sold 10,300 MiMedx Group shares in Q2 2022, an estimated $49K.
CoreFirst Bank & Trust first reported a position in MiMedx Group in Q4 2020 and held it in 6 quarters.
CoreFirst Bank & Trust's MiMedx Group position peaked at $129K in Q2 2021.
153 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2022.

Based on CoreFirst Bank & Trust's 13F filing for Q2 2022, filed 16 Aug 2022.